Saturday, March 24, 2007

Interesting Research in Heart Disease

This article describes some current research which I learned about through my interest in investments. A biotech company I invested in this week will report on some research tomorrow involving the injection of stem cells into the hearts of patients with recent heart attacks in a Phase 1 study. The results, I understand, were very positive and I expect the stock to do quite well, but the benefits to attack victims down the road may be even better. The company is Osiris Therapeutics Inc., stock symbol OSIR.

Personal Unsecured Loan